-
[1]
Xiaoyong Zhang, Suwen Lu, Hui Li, Yi Wang, Zhen Lu, Zhihong Liu, Qingtao Lai, Yali Ji, Xuan Huang, Yongyin Li, Jian Sun, Yingsong Wu, Xiaoning Xu, Jinlin Hou, 2020: Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study, Virologica Sinica, 35, 820-829. doi: 10.1007/s12250-020-00329-9
-
[2]
Yuqi Zhu, Xinyi Yang, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao, Jing Wang, Hanyu Pan, Jinlong Yang, Zhiming Liang, Yue Liang, Qinru Lin, Huitong Liang, Min Li, Jianping Liu, Yinzhong Shen, Xiaoyan Zhang, Pengfei Wang, Daru Lu, Chunhua Yin, Jianqing Xu, Shibo Jiang, Hongzhou Lu, Huanzhang Zhu, 2022: Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum, Virologica Sinica, 37, 831-841. doi: 10.1016/j.virs.2022.10.006
-
[3]
Wenyi Guan, Wendong Lan, Jing Zhang, Shan Zhao, Junxian Ou, Xiaowei Wu, Yuqian Yan, Jianguo Wu, Qiwei Zhang, 2020: COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine, Virologica Sinica, 35, 685-698. doi: 10.1007/s12250-020-00297-0
-
[4]
Yongran Wu, Ke Hong, Lianguo Ruan, Xiaobo Yang, Jiancheng Zhang, Jiqian Xu, Shangwen Pan, Lehao Ren, Lu Chen, Chaolin Huang, You Shang, 2020: Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study, Virologica Sinica, 35, 768-775. doi: 10.1007/s12250-020-00281-8
-
[5]
Suyan Tian, Xuetong Zhu, Xuejuan Sun, Jinmei Wang, Qi Zhou, Chi Wang, Li Chen, Shanji Li, Jiancheng Xu, 2020: A Prognostic Model to Predict Recovery of COVID-19 Patients Based on Longitudinal Laboratory Findings, Virologica Sinica, 35, 811-819. doi: 10.1007/s12250-020-00317-z
-
[6]
Huaqing Shu, Shuzhen Wang, Shunan Ruan, Yaxin Wang, Jiancheng Zhang, Yin Yuan, Hong Liu, Yongran Wu, Ruiting Li, Shangwen Pan, Yaqi Ouyang, Shiying Yuan, Peng Zhou, You Shang, 2020: Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak, Virologica Sinica, 35, 744-751. doi: 10.1007/s12250-020-00268-5
-
[7]
Ke Hu, Mengmei Wang, Yang Zhao, Yunting Zhang, Tao Wang, Zhishui Zheng, Xiaochen Li, Shaolin Zeng, Dong Zhao, Honglin Li, Ke Xu, Ke Lan, 2020: A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial, Virologica Sinica, 35, 725-733. doi: 10.1007/s12250-020-00258-7
-
[8]
Shichuan Wang, Mirko Trilling, Kathrin Sutter, Ulf Dittmer, Mengji Lu, Xin Zheng, Dongliang Yang, Jia Liu, 2020: A Crowned Killer's Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2, Virologica Sinica, 35, 673-684. doi: 10.1007/s12250-020-00298-z
-
[9]
Yan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, Xue Hu, Hua-Jun Zhang, Yi-Wu Zhou, Ge Gao, Ying Chen, Yun Peng, Mei-Qin Liu, Ya-Nan Zhang, Juan Min, Jia Lu, Xiao-Xiao Gao, Jing Guo, Cheng Peng, Xu-Rui Shen, Qian Li, Kai Zhao, Lian Yang, Xin Wan, Bo Zhang, Wen-Hui Wang, Jia Wu, Peng Zhou, Xing-Lou Yang, Shuo Shen, Chao Shan, Zhi-Ming Yuan, Zheng-Li Shi, 2021: Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates, Virologica Sinica, 36, 879-889. doi: 10.1007/s12250-021-00376-w
-
[10]
Hongming Huang, Jia Liu, 2023: Role of inactivated SARS-CoV-2 vaccine induced T cell responses in ameliorating COVID-19 severity, Virologica Sinica, 38, 324-326. doi: 10.1016/j.virs.2023.02.003
-
[11]
Bali Zhao, Maohua Zhong, Qingyu Yang, Ke Hong, Jianbo Xia, Xia Li, Ying Liu, Yao-Qing Chen, Jingyi Yang, Chaolin Huang, Huimin Yan, 2021: Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study, Virologica Sinica, 36, 859-868. doi: 10.1007/s12250-021-00348-0
-
[12]
Ziwei Li, Tiandan Xiang, Boyun Liang, Jing Liu, Hui Deng, Xuecheng Yang, Hua Wang, Xuemei Feng, Gennadiy Zelinskyy, Mirko Trilling, Kathrin Sutter, Mengji Lu, Ulf Dittmer, Baoju Wang, Dongliang Yang, Xin Zheng, Jia Liu, 2023: SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection, Virologica Sinica, 38, 606-619. doi: 10.1016/j.virs.2023.06.011
-
[13]
Yingshuo Ma, Man Li, Lyu Xie, Na Gao, Dongying Fan, Kaihao Feng, Yao Yao, Yong Zhou, Ziyang Sheng, Hongning Zhou, Hui Chen, Jing An, 2021: Seroepidemiologic Study on Convalescent Sera from Dengue Fever Patients in Jinghong, Yunnan, Virologica Sinica.
-
[14]
Yingshuo Ma, Man Li, Lyu Xie, Na Gao, Dongying Fan, Kaihao Feng, Yao Yao, Yong Zhou, Ziyang Sheng, Hongning Zhou, Hui Chen, Jing An, 2022: Seroepidemiologic study on convalescent sera from dengue fever patients in Jinghong, Yunnan, Virologica Sinica, 37, 19-29. doi: 10.1016/j.virs.2021.12.001
-
[15]
Xiaojun Wu, Tong Wang, Yilu Zhou, Xiaofan Liu, Hong Zhou, Yang Lu, Weijun Tan, Mingli Yuan, Xuhong Ding, Jinjing Zou, Ruiyun Li, Hailing Liu, Rob M. Ewing, Yi Hu, Hanxiang Nie, Yihua Wang, 2020: Different Laboratory Abnormalities in COVID-19 Patients with Hypertension or Diabetes, Virologica Sinica, 35, 853-856. doi: 10.1007/s12250-020-00296-1
-
[16]
Zhihua Bai, Yue Gong, Xiaodong Tian, Ying Cao, Wenjun Liu, Jing Li, 2020: The Rapid Assessment and Early Warning Models for COVID-19, Virologica Sinica, 35, 272-279. doi: 10.1007/s12250-020-00219-0
-
[17]
Carlos M. Chiesa-Estomba, Jerome R. Lechien, Maria R. Barillari, Sven Saussez, 2020: Patterns of Gustatory Recovery in Patients Affected by the COVID-19 Outbreak, Virologica Sinica, 35, 833-837. doi: 10.1007/s12250-020-00272-9
-
[18]
Junsen Chen, Rui Huang, Yiwen Nie, Xinyue Wen, Ying Wu, 2020: Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19, Virologica Sinica, 35, 713-724. doi: 10.1007/s12250-020-00327-x
-
[19]
Xiaohua Chen, Juan Zhou, Chen Chen, Baidong Hou, Ashaq Ali, Feng Li, Zhaolin Hua, Yingtao Wu, Qin Yang, Min Chen, Rong Zhang, Qianchuan Huang, Jinya Ding, Xian-En Zhang, Dong Men, 2021: Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients, Virologica Sinica, 36, 1093-1096. doi: 10.1007/s12250-021-00425-4
-
[20]
Junwei Li, Mingyue Song, Deyin Guo, Yongxiang Yi, 2021: Safety and Considerations of the COVID-19 Vaccine Massive Deployment, Virologica Sinica, 36, 1097-1103. doi: 10.1007/s12250-021-00408-5